Evaluation of cholecystokinin (CCK-8) peptide thermal stability for use as radiopharmaceutical by means isothermal and nonisothermal approaches. | Drug Dev Ind Pharm;32(8): 947-53, 2006 Sep. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Evaluation of cholecystokinin (CCK-8) peptide thermal stability for use as radiopharmaceutical by means isothermal and nonisothermal approaches.

Oliva, A; Hidalgo, M; Alvarez, C; Llabrés, M; Fariña, J B.

Affiliation

Oliva A; Departamento de Ingeniería Química y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de La Laguna, 38200, La Laguna, Tenerife, Spain. amoliva@ull.es

Drug Dev Ind Pharm ; 32(8): 947-53, 2006 Sep.

Article in En | MEDLINE | ID: mdl-16954107

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Sincalide / Radiopharmaceuticals Language: En Journal: Drug Dev Ind Pharm Year: 2006 Document type: Article Affiliation country: España Country of publication: Reino Unido

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Sincalide / Radiopharmaceuticals Language: En Journal: Drug Dev Ind Pharm Year: 2006 Document type: Article Affiliation country: España Country of publication: Reino Unido